Research Applications of Sermorelin Acetate
Sermorelin acetate is a synthetic growth hormone releasing hormone (GHRH) analogue peptide consisting of the first 29 amino acids of human GHRH. As researchers investigate endocrine function mechanisms, this compound offers significant value for examining growth hormone axis modulation in controlled laboratory environments. The peptide binds to GHRH receptors on anterior pituitary somatotrophs, stimulating the natural release of growth hormone in preclinical models.
Investigators studying metabolic regulation and hormonal signaling pathways frequently examine sermorelin’s effects on pulsatile GH secretion patterns. Research applications include investigations into age-related GH decline, circadian rhythm studies, and comparative analyses with other growth hormone secretagogues. The compound’s ability to preserve physiological feedback mechanisms makes it valuable for research requiring natural hormone dynamics rather than exogenous GH administration.
Technical Specifications
| Parameter | Specification |
|---|---|
| Chemical Name | Sermorelin Acetate |
| CAS Number | 86168-78-7 |
| Molecular Formula | C₁₄₉H₂₄₆N₄₄O₄₂S · C₂H₄O₂ |
| Molecular Weight | 3357.96 g/mol |
| Purity | ≥98% (HPLC) |
| Form | Lyophilised powder |
| Storage | -20°C, protect from light |
| Vial Size | 2mg |
Research Applications and Mechanisms
Advanced research protocols utilise sermorelin acetate to investigate the hypothalamic-pituitary-growth hormone axis in various experimental models. Scientists at Stroid UK Shop study this compound’s receptor binding kinetics and downstream signaling cascades. When examining peptide hormones, sermorelin provides insights into natural GH regulation mechanisms without the complications associated with direct hormone administration.
Comparative studies often evaluate sermorelin alongside other growth hormone secretagogues available through our sermorelin research collection. Researchers investigating metabolic pathways may combine sermorelin studies with examinations of selective androgen receptor modulators to understand comprehensive hormonal interactions. The peptide’s short half-life requires specific timing protocols for optimal research outcomes.
Laboratory Use and Compliance
This sermorelin acetate preparation is manufactured exclusively for in-vitro research purposes and is not approved for human consumption, therapeutic use, or clinical applications. Researchers must maintain proper storage conditions and handle the compound according to institutional safety protocols. All studies should comply with relevant research guidelines and institutional review board requirements for peptide hormone research.
